Peptic ulcer disease

Mark H. Ebell

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Peptic ulcer disease affects between 5 percent and 10 percent of Americans during their lifetime. There are a variety of predisposing factors, including nonsteroidal anti-inflammatory drug (NSAID) use, Helicobacter pylori infection, tobacco use and, possibly, certain dietary practices. While H2- receptor antagonists remain the mainstay of therapy, the selection of an antiulcer drug should be individualized. Famotidine is preferred in persons who use alcohol, sucralfate may be preferred for maintenance therapy in smokers and omeprazole is useful in hypersecretors of acid and in patients with resistant ulcers. Antacids remain an effective treatment for uncomplicated duodenal ulcer in motivated patients. Eradication of H. pylori using a bismuth preparation plus one or two antibiotic agents should be considered in patients who have frequent recurrences and evidence of infection. Finally, risk factors such as tobacco or NSAID use should be modified whenever possible to reduce the risk of ulcer recurrence.

Original languageEnglish (US)
Pages (from-to)217-227
Number of pages11
JournalAmerican family physician
Volume46
Issue number1
StatePublished - Jul 27 1992

Fingerprint

Peptic Ulcer
Helicobacter pylori
Ulcer
Anti-Inflammatory Agents
Pharmaceutical Preparations
Sucralfate
Famotidine
Recurrence
Antacids
Histamine H2 Receptors
Bismuth
Omeprazole
Tobacco Use
Helicobacter Infections
Duodenal Ulcer
Causality
Tobacco
Therapeutics
Alcohols
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Family Practice

Cite this

Ebell, M. H. (1992). Peptic ulcer disease. American family physician, 46(1), 217-227.

Peptic ulcer disease. / Ebell, Mark H.

In: American family physician, Vol. 46, No. 1, 27.07.1992, p. 217-227.

Research output: Contribution to journalReview article

Ebell, MH 1992, 'Peptic ulcer disease', American family physician, vol. 46, no. 1, pp. 217-227.
Ebell MH. Peptic ulcer disease. American family physician. 1992 Jul 27;46(1):217-227.
Ebell, Mark H. / Peptic ulcer disease. In: American family physician. 1992 ; Vol. 46, No. 1. pp. 217-227.
@article{d51cd40d4f054fcbbb497ce222b0ce7a,
title = "Peptic ulcer disease",
abstract = "Peptic ulcer disease affects between 5 percent and 10 percent of Americans during their lifetime. There are a variety of predisposing factors, including nonsteroidal anti-inflammatory drug (NSAID) use, Helicobacter pylori infection, tobacco use and, possibly, certain dietary practices. While H2- receptor antagonists remain the mainstay of therapy, the selection of an antiulcer drug should be individualized. Famotidine is preferred in persons who use alcohol, sucralfate may be preferred for maintenance therapy in smokers and omeprazole is useful in hypersecretors of acid and in patients with resistant ulcers. Antacids remain an effective treatment for uncomplicated duodenal ulcer in motivated patients. Eradication of H. pylori using a bismuth preparation plus one or two antibiotic agents should be considered in patients who have frequent recurrences and evidence of infection. Finally, risk factors such as tobacco or NSAID use should be modified whenever possible to reduce the risk of ulcer recurrence.",
author = "Ebell, {Mark H.}",
year = "1992",
month = "7",
day = "27",
language = "English (US)",
volume = "46",
pages = "217--227",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "1",

}

TY - JOUR

T1 - Peptic ulcer disease

AU - Ebell, Mark H.

PY - 1992/7/27

Y1 - 1992/7/27

N2 - Peptic ulcer disease affects between 5 percent and 10 percent of Americans during their lifetime. There are a variety of predisposing factors, including nonsteroidal anti-inflammatory drug (NSAID) use, Helicobacter pylori infection, tobacco use and, possibly, certain dietary practices. While H2- receptor antagonists remain the mainstay of therapy, the selection of an antiulcer drug should be individualized. Famotidine is preferred in persons who use alcohol, sucralfate may be preferred for maintenance therapy in smokers and omeprazole is useful in hypersecretors of acid and in patients with resistant ulcers. Antacids remain an effective treatment for uncomplicated duodenal ulcer in motivated patients. Eradication of H. pylori using a bismuth preparation plus one or two antibiotic agents should be considered in patients who have frequent recurrences and evidence of infection. Finally, risk factors such as tobacco or NSAID use should be modified whenever possible to reduce the risk of ulcer recurrence.

AB - Peptic ulcer disease affects between 5 percent and 10 percent of Americans during their lifetime. There are a variety of predisposing factors, including nonsteroidal anti-inflammatory drug (NSAID) use, Helicobacter pylori infection, tobacco use and, possibly, certain dietary practices. While H2- receptor antagonists remain the mainstay of therapy, the selection of an antiulcer drug should be individualized. Famotidine is preferred in persons who use alcohol, sucralfate may be preferred for maintenance therapy in smokers and omeprazole is useful in hypersecretors of acid and in patients with resistant ulcers. Antacids remain an effective treatment for uncomplicated duodenal ulcer in motivated patients. Eradication of H. pylori using a bismuth preparation plus one or two antibiotic agents should be considered in patients who have frequent recurrences and evidence of infection. Finally, risk factors such as tobacco or NSAID use should be modified whenever possible to reduce the risk of ulcer recurrence.

UR - http://www.scopus.com/inward/record.url?scp=0026631407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026631407&partnerID=8YFLogxK

M3 - Review article

C2 - 1621633

AN - SCOPUS:0026631407

VL - 46

SP - 217

EP - 227

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 1

ER -